Erectile difficulties can involve more than testosterone. Learn why assessment includes medical history, medications, cardiovascular risk and metabolic tests.
No, erectile dysfunction has several possible causes, and low testosterone is only one factor a clinician may consider.
This article is for informational purposes only and is not medical advice. Personal assessment and treatment decisions belong with a qualified clinician.
Erectile difficulties deserve a wider assessment because hormonal and nonhormonal contributors can overlap. The European Association of Urology (EAU) describes erectile dysfunction (ED) as potentially vascular or hormonal. It also identifies neurological and anatomical causes alongside medication effects and psychological factors.
More than one contributor may be present in the same person. That makes an either-or question misleading: asking whether ED is hormonal or physical separates categories that may coexist.
Rather than picking a cause in advance, a useful starting point is to ask which aspects of health need attention together. The EAU's assessment includes a medical and sexual history as well as examination and laboratory testing. Hormone measurements sit within that wider process.
The EAU associates ED with increased cardiovascular risk and advises considering it a possible precursor of cardiovascular disease. This is an association, not proof that an individual man with erection difficulty has heart disease.
For men whose ED appears mainly blood-vessel related, the guideline describes a formal cardiovascular risk assessment. The purpose is to consider the wider health context rather than viewing the symptom only as a sexual-function problem.
A practical question for a clinician is whether cardiovascular risk needs attention in the assessment. The cardiometabolic context of erection changes is relevant to that discussion even when testosterone testing is also being considered.
This broader view changes the question from “Is my testosterone low?” to “What does this symptom mean in my health history?” Both questions can be discussed during the same appointment.
Metabolic testing is another part of the EAU's recommended ED work-up. The guideline lists diabetes and abnormal blood lipids among conditions associated with ED. High blood pressure, obesity and metabolic syndrome are also on that list.
For laboratory assessment, the EAU recommends fasting blood glucose or HbA1c and a lipid profile if these have not been assessed in the previous 12 months. These recommendations sit alongside its recommendation for hormone testing.
The useful question is which relevant results are already available and what needs updating. Bringing existing test information into the discussion helps keep the review focused on the guideline's metabolic and hormonal questions together.
These measurements address different parts of the assessment. A testosterone result does not replace the metabolic information included in the EAU's recommended evaluation.
Yes. The EAU lists some blood pressure medicines and antidepressants as possible contributors to ED. This makes a medication review relevant, but the list does not identify the cause of an individual man's symptoms.
Do not stop or change prescribed medication on your own. A qualified clinician can review medicines alongside the symptom history and the conditions for which they were prescribed.
To prepare for that conversation, describe what medication is being taken and when the erectile concern began. The aim is to provide a clear history rather than decide in advance which prescription is responsible.
Yes. The EAU includes psychological causes in its description of ED alongside physical causes and medication effects. Asking about sexual context is therefore part of the recommended assessment, not a reason to dismiss the concern.
The history should give the clinician a clear account of what has changed. Describe the erectile difficulty and the context in which it occurs rather than offering only a conclusion such as “my testosterone must be low.”
If sexual desire has also changed, mention that separately. Keeping desire and erection concerns distinct makes the account more specific. The clinician can then consider both within the wider medical and sexual history recommended by the EAU.
Testosterone testing belongs within the ED assessment. The EAU includes early-morning total testosterone measured in a fasting state among its laboratory recommendations.
Interpreting that result raises a separate question: is there evidence of hypogonadism, or testosterone deficiency? In its male-hypogonadism guideline, the EAU requires compatible signs or symptoms together with consistently low morning testosterone. It recommends repeat measurement before testosterone therapy when the initial result is low.
One low result therefore does not establish the diagnosis. The diagnostic question depends on symptoms and consistent findings rather than an isolated number.
The EAU also notes that calculated free testosterone or bioavailable testosterone may sometimes help clarify total testosterone measurements. Whether those supporting measurements are relevant is a question for the assessing clinician.
A useful discussion covers why the hormone test is being considered and how its result fits the symptom history. This gives the measurement a clinical purpose within the broader assessment.
Testosterone replacement therapy (TRT) may be considered when clinically indicated in selected men with low or low-normal testosterone and related sexual problems, according to the EAU. Those problems may include reduced sexual desire or erectile function.
The wording is conditional. It does not promise that testosterone therapy will resolve erectile difficulties when several contributors may be involved.
This treatment statement belongs alongside the diagnostic guidance rather than replacing it. A clinician considers whether the assessment supports a testosterone-related diagnosis and whether treatment is appropriate.
For someone considering TRT, a useful question is: “Which findings support this option, and which other factors still need attention?” That keeps the conversation focused on a clinical rationale rather than expecting a hormone treatment to answer every sexual-health concern.
An endocrinologist or another assessing physician brings these questions together through the history, examination and relevant laboratory results. The EAU places detailed medical and sexual history first in the ED evaluation.
It also recommends a physical examination focused on the genitourinary and endocrine systems as well as vascular and neurological findings. In plain language, that includes reproductive and urinary health along with hormones, blood vessels and nerves.
The evaluation connects the questions raised throughout this article. The medical history puts known conditions and medication use alongside the sexual history. Laboratory results add information about metabolic health and testosterone rather than replacing those histories.
Useful points to bring into the conversation include:
These are discussion topics drawn from the guideline's assessment framework. They are not a self-testing protocol. For persistent or concerning erectile difficulties, a qualified clinician can assess the combined picture and decide which findings need further attention.
For related context, this guide to concurrent erection and hormone concerns explains why these questions belong in one clinical conversation.
The central clinical message is to discuss erectile function in the context of overall health while giving testosterone its appropriate place. A useful assessment connects the symptom history to examination findings and relevant metabolic and hormonal tests.
For men preparing for an appointment, the immediate goal is a clear description of the concern and informed questions about the assessment.
How might future research help clinicians better identify the relative roles of vascular health, metabolic factors and testosterone in men whose erectile difficulties have several contributors?
Choosing questions for an erectile-function assessment starts with the symptom rather than a presumed hormone cause, and Testostra supports that distinction through evidence-led education. For men uncertain about possible low testosterone symptoms, its coverage puts testing and other possible causes into context without offering personal diagnoses or hormone protocols.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra